Cargando…

Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease

INTRODUCTION: Chronic graft-versus-host disease (cGVHD) is a serious immune-mediated complication after allogeneic haematopoietic stem cell transplantation (HSCT), but in patients with malignancy, cGVHD development is associated with superior survival. Lack of reliable biomarkers and clinical underr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novitzky-Basso, Igor, Schain, Frida, Batyrbekova, Nurgul, Webb, Thomas, Remberger, Mats, Keating, Armand, Mattsson, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997892/ https://www.ncbi.nlm.nih.gov/pubmed/36893113 http://dx.doi.org/10.1371/journal.pone.0282753

Ejemplares similares

Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
por: Schain, Frida, et al.
Publicado: (2020)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
por: Afram, Gabriel, et al.
Publicado: (2019)

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
por: Stikvoort, Arwen, et al.
Publicado: (2017)

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
por: Remes, Kari, et al.
Publicado: (2018)

PB2001: PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES- A SWEDISH RETROSPECTIVE REAL-WORLD STUDY
por: Schain, Frida, et al.
Publicado: (2023)

Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
por: Pang, Ian, et al.
Publicado: (2022)

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
por: Poiret, Thomas, et al.
Publicado: (2014)

Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
por: Schain, Frida, et al.
Publicado: (2019)

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017)

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c(+) Expression in Tumor
por: Magalhaes, Isabelle, et al.
Publicado: (2020)

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: El‐Serafi, Ibrahim, et al.
Publicado: (2019)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei, Cong, et al.
Publicado: (2021)

PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
por: José Jiménez Nájar, Francisco, et al.
Publicado: (2023)

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
por: Poiret, Thomas, et al.
Publicado: (2018)

Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations
por: Novitzky-Basso, Igor, et al.
Publicado: (2022)

Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Sairafi, Darius, et al.
Publicado: (2016)

Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
por: Spałek, Adrianna, et al.
Publicado: (2022)

Antibiotic Therapy and Risk of Early-Onset Colorectal Cancer: A National Case-Control Study
por: Nguyen, Long H., et al.
Publicado: (2022)

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
por: El-Serafi, Ibrahim, et al.
Publicado: (2018)

The Impact of Age on Clinical Outcomes of Coronary Artery Bypass Grafting: Long-Term Results of a Real-World Registry
por: Nicolini, Francesco, et al.
Publicado: (2017)

Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
por: Wobma, Holly, et al.
Publicado: (2023)

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
por: Ringdén, Olle, et al.
Publicado: (2011)

P1372: REAL-WORLD RETROSPECTIVE ANALYSIS OF INFECTIOUS COMPLICATIONS AFTER RUXOLITNIB USE IN ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE
por: Sol Reis, C., et al.
Publicado: (2022)

Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study
por: Perić, Zinaida, et al.
Publicado: (2023)

PW02-008 - TRAPS in the real world: an international registry
por: Lachmann, HJ, et al.
Publicado: (2013)

Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines
por: Novitzky-Basso, Igor, et al.
Publicado: (2012)

P1382: RUXOLITINIB USE IN A REAL WORLD ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE COHORT IN THE NETHERLANDS: A RETROSPECTIVE STUDY
por: Van Der Wagen, L., et al.
Publicado: (2022)

Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant
por: Pelletier, Karyne, et al.
Publicado: (2022)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

A National Spinal Muscular Atrophy Registry for Real-World Evidence
por: Hodgkinson, Victoria L., et al.
Publicado: (2020)

Biologics in severe asthma: the role of real-world evidence from registries
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
por: Gall, Rebecca, et al.
Publicado: (2023)

Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation
por: Fujii, Hisaki, et al.
Publicado: (2015)

Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study
por: Sabatelli, Lorenzo, et al.
Publicado: (2022)

Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
por: Bonig, Halvard, et al.
Publicado: (2023)

A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry
por: Kleinert, Stefan, et al.
Publicado: (2021)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Building medical knowledge from real world registries: The case of heart failure
por: Aimo, Alberto, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gbfj1o9d4rba08ntn2ipj9buk7